The document discusses the need for alternatives to animal experiments in pharmacological research due to ethical concerns and regulatory requirements. It introduces the 3R strategy—refinement, reduction, and replacement—to minimize animal suffering and improve research methods by utilizing in-vitro models and computer simulations. Additionally, it highlights various in-vitro techniques and their applications, emphasizing the move towards non-animal testing methods.
Related topics: